Geoffrey D'hondt

As part of the HERAN team, Geoffrey supported with the investments in Thirona and ImmuneSpec. He gained first experience in investment management at Gimv before joining Valiance where he built a track record in venture-backed healthcare investments. 

Through his position of Investment Director, Geoffrey is predominately focused on deal flow and several portfolio com­panies. Geoffrey holds a Master’s in Business Economics from Ghent University and an Advanced Master’s in Finance from ESCP Europe.